Galenic formulation for colon-targeted delivery of active ingredients
US7833765B2 · kind B2 · utility
1Cited by
7References
31Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 29, 2008 |
| Grant date | Nov 16, 2010 |
| Priority date | — |
| Expiry date | Apr 1, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns multiparticulate galenic formulations for oral administration and designed for colon targeted delivery of active principles selected from the group comprising enzymes capable of inactivating macrolides and the like, enzymes capable of inactivating quinolones and β-lactamases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.